RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1748845
Cerebral Aspergillosis in an Immunocompetent Patient after COVID-19 Infection
Aspergilose Cerebral em Paciente Imunocompetente após Infecção por COVID-19
Abstract
Fungal brain abscesses are an uncommon condition in the immunocompetent population, especially due to the etiologic agent Aspergillus sp. The emerging coronavirus disease 2019 (COVID-19) pandemic brought about neurological manifestations that were previously little known, caused by the direct manifestations of the virus, as well as by the therapy itself, with hospitalization and use of corticosteroids. This manuscript highlights the need for attention in the management of patients with neurological disorders and history of COVID-19 infection. In the current paper, we report the case of a patient without comorbidities who presented multiple brain abscesses caused by Aspergillus fumigatus, after infection by Severe Acute Respiratory Syndrome Coronavírus 2 (SARS-CoV-2).
Resumo
Abscessos cerebrais fúngicos são uma condição incomum na população imunocompetente, especialmente quando provocada pelo agente etiológico Aspergillus sp. A epidemia emergente do novo coronavírus (COVID-19) trouxe acometimentos neurológicos até então pouco conhecidos, ocasionados pelas manifestações diretas do vírus, como também pela própria terapia, com internação e uso de corticoesteróides. Este manuscrito destaca a necessidade de atenção no manejo de pacientes com alterações neurológicas e história de infecção pelo vírus. No presente trabalho, relatamos o caso de um paciente sem comorbidades que apresentava múltiplos abscessos cerebrais causados por Aspergillus fumigatus, após infecção pelo SARS-CoV-2.
Informed Consent
The patient's family consented to the presentation of the case for submission to the journal.
Publikationsverlauf
Eingereicht: 22. Dezember 2021
Angenommen: 06. April 2022
Artikel online veröffentlicht:
07. Juli 2022
© 2022. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Ellenbogen JR, Waqar M, Cooke RP, Javadpour M. Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review. Br J Neurosurg 2016; 30 (03) 280-285
- 2 Ma Y, Li W, Ao R. et al. Central nervous system aspergillosis in immunocompetent patients: Case series and literature review. Medicine (Baltimore) 2020; 99 (44) e22911
- 3 Ruhnke M, Kofla G, Otto K, Schwartz S. CNS aspergillosis: recognition, diagnosis and management. CNS Drugs 2007; 21 (08) 659-676
- 4 Spapen H, Spapen J, Taccone FS. et al; AspICU Study Investigators. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. Int J Antimicrob Agents 2014; 43 (02) 165-169
- 5 Stevens DA, Melikian GL. Aspergillosis in the ‘nonimmunocompromised’ host. Immunol Invest 2011; 40 (7-8): 751-766
- 6 Louati I, Zaouali J, Azzouz O. et al. [Cerebral aspergillosis in immunocompetent patients: three case reports]. Rev Neurol (Paris) 2009; 165 (11) 957-961
- 7 Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18 (05) 574-582
- 8 Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19 (03) 402-408
- 9 Boes B, Bashir R, Boes C, Hahn F, McConnell JR, McComb R. Central nervous system aspergillosis. Analysis of 26 patients. J Neuroimaging 1994; 4 (03) 123-129
- 10 Jantunen E, Volin L, Salonen O. et al. Central nervous system aspergillosis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2003; 31 (03) 191-196
- 11 Tattevin P, Jauréguiberry S, Gangneux JP. [Cerebral aspergillosis]. Rev Neurol (Paris) 2004; 160 (5 Pt 1): 597-605
- 12 Beraldo D, Guerra R, Alvarenga V, Crepaldi L. Surgical Treatment Alone of Cerebral Aspergillosis in Immunocompetent Patient. J Neurol Surg A Cent Eur Neurosurg 2016; 77 (05) 452-456
- 13 Marzolf G, Sabou M, Lannes B. et al. Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations. PLoS One 2016; 11 (04) e0152475
- 14 Wang RX, Zhang JT, Chen Y, Huang XS, Jia WQ, Yu SY. Cerebral aspergillosis: a retrospective analysis of eight cases. Int J Neurosci 2017; 127 (04) 339-343
- 15 Hall WA. Improving outcomes in cerebral aspergillosis. World Neurosurg 2014; 82 (1-2): e139-e140
- 16 Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 2020; 12 (01) 69
- 17 Satarker S, Nampoothiri M. Involvement of the nervous system in COVID-19: The bell should toll in the brain. Life Sci 2020; 262: 118568
- 18 Gupta V, Singh P, Sukriti K. Fungal brain abscess in a post COVID-19 patient. BMJ Case Rep 2021; 14 (09) e246319
- 19 Hakamifard A, Hashemi M, Fakhim H, Aboutalebian S, Hajiahmadi S, Mohammadi R. Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus. J Mycol Med 2021; 31 (02) 101124